Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trial Marabelle, Aurelien; O'Malley, David M.; Hendifar, Andrew E.; Ascierto, Paolo A.; Motola-Kuba, Daniel; Penel, Nicolas; Cassier, Philippe A.; Bariani, Giovanni; De Jesus-Acosta, Ana; Doi, Toshihiko; Longo, Federico; Miller, Wilson H.; Oh, Do-Youn; Gottfried, Maya; Yao, Lili; Jin, Fan; Gozman, Alexander; Maio, Michele Share Save
Open-label, phase Ia study of STING agonist BI 1703880 plus ezabenlimab for patients with advanced solid tumors Harrington, Kevin; Kitano, Shigehisa; Gambardella, Valentina; Parkes, Eileen E.; Moreno, Irene; Alonso, Guzman; Doi, Toshihiko; Berz, David; Gutierrez, Martin E.; Fernandez, Natalia; Schmohl, Michael; Barrueco, Jose; LoRusso, Patricia Share Save
First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration5 Rodon, J.; Prenen, H.; Sacher, A.; Villalona-Calero, M.; Penel, N.; El Helali, A.; Rottey, S.; Yamamoto, N.; Ghiringhelli, F.; Goebeler, M. E.; Doi, T.; Postel-Vinay, S.; Lin, C. -c.; Liu, C.; Chuang, C. -h.; Keyvanjah, K.; Eggert, T.; Neil, B. h. o ' Share Save
Share Save
Share Save
A phase 1/1b, open-label, dose-escalation study of PD-1 inhibitor, cetrelimab alone and in combination with FGFR inhibitor, erdafitinib in Japanese patients with advanced solid tumors Yamamoto, Noboru; Kuboki, Yasutoshi; Harano, Kenichi; Koyama, Takafumi; Kondo, Shunsuke; Hagiwara, Akiko; Suzuki, Noriko; Fujikawa, Ei; Toyoizumi, Kiichiro; Mukai, Mayumi; Doi, Toshihiko Share Save
A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiency Kohsaka, Shinji; Yagishita, Shigehiro; Shirai, Yukina; Matsuno, Yusuke; Ueno, Toshihide; Kojima, Shinya; Ikeuchi, Hiroshi; Ikegami, Masachika; Kitada, Rina; Yoshioka, Ken-ichi; Toshimitsu, Kohta; Tabata, Kimiyo; Yokoi, Akira; Doi, Toshihiko; Yamamoto, Noboru; Owa, Takashi; Hamada, Akinobu; Mano, Hiroyuki Share Save
LEAP-014: first-line lenvatinib plus pembrolizumab plus chemotherapy in advanced/metastatic esophageal squamous cell carcinoma Sun, Jong-Mu; Adenis, Antoine; Enzinger, Peter C.; Shah, Manish A.; Kato, Ken; Bennouna, Jaafar; Doi, Toshihiko; Hawk, Natalyn Nicole; Yu, Li; Shah, Sukrut; Bhagia, Pooja; Shen, Lin Share Save
Share Save
KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non-small-cell lung cancer Yamamoto, Noboru; Satouchi, Miyako; Doi, Toshihiko; Fujiwara, Yutaka; Yanagitani, Noriko; Kawa, Yoshitaka; Yoh, Kiyotaka; Leopold, Lance; Munteanu, Mihaela; Sawada, Takashi; Han, Shirong; Noguchi, Kazuo; Nishio, Makoto Share Save
The mechanism of gut microbiome-mediated immune activation on the clinical efficacy of PD-1 blocking treatment in solid tumors Lin, Nina Yi-Tzu; Fukuoka, Shota; Motooka, Daisuke; Shigeno, Yuko; Irie, Takuma; Tourlousse, Dieter M.; Murotomi, Kazutoshi; Sekiguchi, Yuji; Tamaki, Hideyuki; Shindo, Mariko; Tsuji, Takahiro; Wake, Hiroaki; Goto, Koichi; Doi, Toshihiko; Shitara, Kohei; Watanabe, Keisuke; Maeda, Yuka; Nakamura, Shota; Benno, Yoshimi; Nishikawa, Hiroyoshi; Koyama, Shohei Share Save
Share Save
Share Save
Initial results from first-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in biomarker-selected solid tumors Rodon, Jordi; Yamamoto, Noboru; Doi, Toshihiko; Ghiringhelli, Francois; Goebeler, Maria-Elisabeth; Fujuwara, Yutaka; Villalona-Calero, Miguel; Penel, Nicolas; Patnaik, Amita; Machiels, Jean-Pascal; Addeo, Alfredo; Abbruzzese, James; Postel-Vinay, Sophie; Rottey, Sylvie; Liu, Chunxu; Chuang, Chen-Hua; Kormany, William; Hughes, Paul; Keyvanjah, Kiana; O'Neil, Bert Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
